Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.35 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.35 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.34 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28198587 | 0.85 | ALOX5 (0.39) | ALOX5ALDH1A1TSHR | |
| SCHEMBL5268183 | 0.83 | ALDH1A1 (0.40) | ALOX5ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL16166282 | 0.79 | SLC1A3 (0.41) | ALOX5ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL6487212 | 0.79 | LMNA (0.44) | ALOX5ALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL27317823 | 0.79 | SLC1A3 (0.36) | ALDH1A1SLC1A3SLC1A2SLC1A1MEN1 | |
| SCHEMBL5275935 | 0.79 | ALDH1A1 (0.35) | ALOX5ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL17170436 | 0.79 | CYP2C9 (0.34) | ALOX5ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL9339995 | 0.78 | ALDH1A1 (0.36) | ALOX5ALDH1A1SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL28010685 | 0.78 | POLB (0.43) | ALOX5ALDH1A1MEN1CYP1A2CYP2C9 | |
| SCHEMBL11051963 | 0.77 | MAOB (0.48) | ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1287006-B1 | ANTITUMORAL COMPOUNDS | PHARMA MAR SA (ES) | 2007-10-24 | — | — | EP | disclosed |
| US-7138547-B2 | Antitumoral compounds | PHARMA MAR, S.A. | 2006-11-21 | — | — | US | disclosed |
| US-20040048834-A1 | Antitumoral compounds | PHARMA MAR, S.A. (ES) | 2004-03-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040048834-A1 | Antitumoral compounds | HCCS, MSR1, SUCNR1 | ALOX5 3204/4885ALDH1A1 1235/4885SLC1A3 2878/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.